Hi Hala,
I thought your discussion of the validity and reliability of the COST outcome measure was compelling. I agree with you that the necessary work of assessing the real strength of the measure will occur through external validation with new data. This seems like a promising model that could potentially have interesting clinical and research consequences.
Neela